https://stock.noler.com/us/stock/gw-pharmaceuticals-plc https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/accounts-payable https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/accounts-receivable https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/accrued-liabilities-current https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/accumulated-depreciation https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/activist-13d-13g-form-sc-13g https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/additional-paid-in-capital-common-stock https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/adjustments-related-to-tax-withholding-for-share-based-compensation https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/allowance-for-doubtful-accounts-receivable-current https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/allowance-for-doubtful-accounts-receivable-write-offs https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/amended-reports-10-k https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/amended-reports-20-f https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/aoci https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/basic-shares https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/capital-expenditures https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/capital-lease-obligations-noncurrent https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/capital-leases-future-minimum-payments-due https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/capital-leases-future-minimum-payments-due-current https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/capital-leases-future-minimum-payments-due-in-five-years https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/capital-leases-future-minimum-payments-due-in-four-years https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/capital-leases-future-minimum-payments-due-in-three-years https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/capital-leases-future-minimum-payments-due-in-two-years https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/capital-leases-future-minimum-payments-due-thereafter https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/capital-leases-future-minimum-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/cash-and-equivalents https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/cash-and-restricted-cash-including-disposal-group-and-discontinued-operations https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/cash-flow-breakdown https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/common-stock-value https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/comprehensive-income https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/contract-with-customer-asset-accumulated-allowance-for-credit-loss https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/contractual-obligation https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/contractual-obligation-due-after-fifth-year https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/contractual-obligation-due-in-fifth-year https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/contractual-obligation-due-in-fourth-year https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/contractual-obligation-due-in-next-twelve-months https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/contractual-obligation-due-in-second-year https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/contractual-obligation-due-in-third-year https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/contractual-obligation-future-minimum-payments-due-remainder-of-fiscal-year https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/cost-of-revenue https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/costs-and-expenses https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/cover-page-shares-outstanding https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/current-assets https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/current-federal-tax-expense-benefit https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/current-income-tax-expense-benefit https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/current-liabilities https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/current-state-and-local-tax-expense-benefit https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/deferred-federal-income-tax-expense-benefit https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/deferred-income-tax-assets-net https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/deferred-income-tax-expense-benefit https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/deferred-income-tax-liabilities https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/deferred-income-taxes-and-tax-credits https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/deferred-state-and-local-income-tax-expense-benefit https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/deferred-tax-assets-gross https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/deferred-tax-assets-liabilities-net https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/deferred-tax-assets-liabilities-net-noncurrent https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/deferred-tax-assets-net https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/deferred-tax-assets-other https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/deferred-tax-assets-property-plant-and-equipment https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/deferred-tax-assets-tax-credit-carryforwards-research https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/deferred-tax-assets-tax-deferred-expense-compensation-and-benefits https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-accrued-liabilities https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-returns-and-allowances https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/deferred-tax-liabilities-property-plant-and-equipment https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/deferred-tax-liabilities-tax-deferred-income https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/depreciation https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/depreciation-and-amortization https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/derivative-asset-notional-amount https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/diluted-shares https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/dilutive-shares https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/effect-of-exchange-rate-on-cash-and-cash-equivalents https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/effective-tax-rate https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/employee-related-liabilities-current https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/eps https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/eps-basic https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/exchange-rate-effect-on-cash https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/finance-lease-interest-expense https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/finance-lease-interest-payment-on-liability https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/finance-lease-liability https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/finance-lease-liability-current https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/finance-lease-liability-noncurrent https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/finance-lease-liability-payments-due https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/finance-lease-liability-payments-due-after-year-five https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/finance-lease-liability-payments-due-next-twelve-months https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/finance-lease-liability-payments-due-year-five https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/finance-lease-liability-payments-due-year-four https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/finance-lease-liability-payments-due-year-three https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/finance-lease-liability-payments-due-year-two https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/finance-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/finance-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/finance-lease-principal-payments https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/finance-lease-right-of-use-asset https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/finance-lease-right-of-use-asset-amortization https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/finance-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/financing-cash-flow https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/foreign-currency-transaction-gain-loss-before-tax https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/foreign-pretax-income https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/gain-loss-on-disposition-of-intangible-assets https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/gain-loss-on-fair-value-hedges-recognized-in-earnings https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/goodwill https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/goodwill-impairment-loss https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/income-tax https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/income-taxes-paid https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/increase-decrease-in-accrued-liabilities https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/increase-decrease-in-income-taxes https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/increase-decrease-in-inventories https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/increase-decrease-in-other-current-liabilities https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/increase-decrease-in-other-operating-assets https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/increase-decrease-in-other-operating-liabilities https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/insider-transactions-other https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/insider-transactions-stock-options https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/insider-transactions-stock-units https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/intangible-assets-net-excluding-goodwill https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/interest-expense https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/interest-paid-net https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/inventory https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/inventory-finished-goods https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/inventory-finished-goods-net-of-reserves https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/inventory-raw-materials https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/inventory-raw-materials-net-of-reserves https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/inventory-work-in-process https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/inventory-work-in-process-net-of-reserves https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/investing-cash-flow https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/investment-income-interest https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/lease-and-rental-expense https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/lease-cost https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/lessee-operating-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/liabilities-noncurrent https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/net-change-in-cash https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/net-income https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/noncash-or-part-noncash-acquisition-fixed-assets-acquired https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/noncurrent-assets https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/number-of-operating-segments https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/oci-net-of-tax https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/operating-cash-flow https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/operating-income https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/operating-lease-assets https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/operating-lease-cost https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/operating-lease-liability https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/operating-lease-liability-current https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/operating-lease-payments https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/operating-lease-payments-due https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/operating-lease-payments-due-2 https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/operating-lease-payments-due-after-year-five https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/operating-lease-payments-due-current https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/operating-lease-payments-due-next-twelve-months https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/operating-lease-payments-due-thereafter https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/operating-lease-payments-due-year-five https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/operating-lease-payments-due-year-four https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/operating-leases-future-minimum-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/other-accrued-liabilities-current https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/other-current-liabilities https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/other-liabilities https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/other-noncash-income-expense https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/other-noncurrent-assets https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/other-noncurrent-liabilities https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/other-nonoperating-income https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/other-sundry-liabilities https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/other-sundry-liabilities-current https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/payments-to-acquire-intangible-assets https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/payments-to-acquire-software https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/pretax-income https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/pretax-income-domestic https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/pretax-income-minority-interest-and-income-loss-from-equity-method-investments https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/proceeds-from-sale-of-intangible-assets https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/proceeds-from-sale-of-property-plant-and-equipment https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/proceeds-from-stock-issued https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/profit-loss https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/property-plant-and-equipment-disposals https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/property-plant-equipment https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/public-float https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/repayments-of-long-term-capital-lease-obligations https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/research-and-development https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/retained-earnings https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/revenue https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/revenue-from-contract-with-customer-excluding-assessed-tax https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/right-of-use-asset-obtained-in-exchange-for-finance-lease-liability https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/right-of-use-asset-obtained-in-exchange-for-operating-lease-liability https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/sale-of-stock-consideration-received-on-transaction https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/sec-comment-letters-corresp https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/sec-comment-letters-drsltr https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/sec-comment-letters-upload https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/sec-filings-10-k https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/sec-filings-10-kt https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/sec-filings-10-q https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/sec-filings-15-12b https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/sec-filings-20-f https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/sec-filings-25-nse https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/sec-filings-6-k https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/sec-filings-8-a12b https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/sec-filings-8-k https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/sec-filings-certnas https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/sec-filings-ct-order https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/sec-filings-def-14a https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/sec-filings-defa14a https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/sec-filings-defm14a https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/sec-filings-dfan14a https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/sec-filings-f-1mef https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/sec-filings-pre-14a https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/sec-filings-prem14a https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/sec-filings-regdex https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/secondary-offerings-form-424b4 https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/secondary-offerings-form-424b5 https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/secondary-offerings-form-drs https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/secondary-offerings-form-effect https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/secondary-offerings-form-f-1 https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/secondary-offerings-form-f-3asr https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/secondary-offerings-form-f-6 https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/secondary-offerings-form-fwp https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/secondary-offerings-form-posasr https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/secondary-offerings-form-s-3asr https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/secondary-offerings-form-s-8 https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/secondary-offerings-form-s-8-pos https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/sga-expense https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/share-price https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/shareholders-equity https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/shares-issued https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/shares-issued-price-per-share https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/stock-award-options-forfeitures-in-period-average-exercise-price https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/stock-based-compensation https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/stock-options-exercisable-average-exercise-price https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/stock-options-exercisable-intrinsic-value https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/stock-options-exercisable-number https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/stock-options-exercises-in-period-total-intrinsic-value https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/stock-options-forfeitures-in-period https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/stock-options-nonvested-grant-date-fair-value https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/stock-options-nonvested-number-of-shares https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/stock-options-nonvested-options-forfeited-grant-date-fair-value https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/stock-options-nonvested-options-forfeited-number-of-shares https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/stock-options-outstanding-number https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/tax-rate-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/tax-rate-reconciliation-foreign-income-tax-rate-differential https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/tax-rate-reconciliation-nondeductible-expense https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/tax-rate-reconciliation-nondeductible-expense-share-based-compensation-cost https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/tax-rate-reconciliation-other-adjustments https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/tax-withholding-on-stock-awards https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/taxes-payable-current https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/total-assets https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/total-liabilities https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/total-liabilities-and-equity https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/unrecognized-tax-benefits https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/utb-decrease-from-prior-year-positions https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/utb-increase-from-current-year-positions https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/utb-increase-from-prior-year-positions https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/utb-reduction-from-statute-lapse https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/utb-that-would-impact-effective-tax-rate https://stock.noler.com/us/stock/gw-pharmaceuticals-plc/weighted-average-number-of-share-outstanding-basic-and-diluted